Integrated bioinformatics analysis identifies cuproptosis and ferroptosis gene signatures via subgroup clustering: Prognostic and therapeutic implications in breast cancer

The cuproptosis/ferroptosis-related genes-based signature serves as a reliable prognostic tool, reflecting immune landscape remodeling and genomic instability in BRCA. These findings provide insights into subtype-specific therapeutic vulnerabilities and suggest potential strategies for targeting cuproptosis/ferroptosis pathways in precision oncology.